3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
2
Skin Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Autoimmune Diseases
1
Interventions
Cyclophosphamide
12
aldesleukin
9
fludarabine
8
fludarabine phosphate
7
pembrolizumab
6
Ipilimumab
5
Interleukin-2
5
Nivolumab
4
dabrafenib
2
Vemurafenib
2
Biopsy
2
Aminolevulinic Acid
2
varlilumab
1
trametinib
1
tilsotolimod
1
spartalizumab
1
sotigalimab
1
sonidegib
1
smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic
1
glembatumumab vedotin
1
eprenetapopt
1
epacadostat
1
encorafenib
1
cemiplimab
1
cabozantinib
1
binimetinib
1
bempegaldesleukin
1
abobotulinumtoxinA
1
X-Rays
1
Tranexamic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Skin Neoplasms
×
Immunotherapy
×
Clear all
NCT03370861
2024-09-05
MINING
Washington University School of Medicine
Terminated
54 enrolled